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Abstract
Background: Bardet-Biedl syndrome is a significant genetic cause of chronic kidney disease in children. Kidney
abnormalities are a major cause of morbidity and mortality in Bardet-Biedl syndrome, but the onset of end-stage
renal disease at an early age and continuous ambulatory peritoneal dialysis, however, are not commonly
mentioned in the literature.
Case presentation: We present the case of a four-year-old Romanian boy who presented to our department with
‘febrile seizures’. After an initial evaluation, we diagnosed our patient as having hypertension, severe anemia and
end-stage renal disease. He met the major and minor criteria for the diagnosis of Bardet-Biedl syndrome and
underwent continuous ambulatory peritoneal dialysis.
Conclusions: Close follow-up for renal involvement in patients with Bardet-Biedl syndrome and Alström syndrome
from an early age is highly recommended to prevent end-stage renal disease and so renal replacement therapy
can be started immediately.
Introduction
Chronic kidney disease is an irreversible condition that
eventually progresses to end-stage renal disease (ESRD).
In children, this can be the result of heterogeneous dis-
eases of the kidney and urinary tract ranging from com-
mon congenital malformations of the urinary tract, to
rare diseases that affect kidney function. ESRD is an
important cause of morbidity and mortality in children
worldwide [1,2].
Bardet-Biedl syndrome (BBS) is a rare, genetic multi-
system disorder; a ciliopathy secondary to the basal
body dysfunction [3,4]. Mutations in 14 genes are
known to be associated with BBS: BBS1, BBS2, ARL6/
BBS3, BBS4, BBS5, MKKS/BBS6, BBS7, TTC8/BBS8, B1/
BBS9, BBS10, TRIM32/BBS11, BBS12, MKS1/BBS13,
and CEP290/BBS14 [5]. BBS shares many similarities
with Alström syndrome, caused by mutations in the
gene ALMS1 and inherited in an autosomal recessive
manner, but Alström syndrome (ALMS) is characterized
by relative preservation of cognitive function and the
absence of polydactyly [6].
Due to the genetic heterogeneity diagnosis of BBS pri-
marily relies on clinical findings and family history. This
pleiotropic disorder has variable expressivity and a wide
range of clinical variability observed both within and
between families [7]. The main clinical features are rod-
cone dystrophy with childhood-onset night blindness
and visual loss, post-axial polydactyly, truncal obesity
that manifests during infancy and remains problematic
throughout adulthood, specific learning difficulties, male
hypogenitalism and complex female genitourinary mal-
formations. Chronic renal dysfunction resulting from
kidney abnormalities is a major cause of morbidity and
mortality [8].
Conventional approaches to end-stage renal disease in
such patients are chronic peritoneal dialysis and hemo-
dialysis followed by kidney transplantation. Continuous
ambulatory peritoneal dialysis, however, is not a com-
monly advocated modality in the literature.
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A four-year-old Romanian boy was admitted to Spitalul
Clinic Judetean de Urgenta Constanta, Romania for ‘feb-
rile seizures’. An initial evaluation revealed hypertension,
severe anemia and end-stage renal disease.
Our patient is the second offspring of consanguineous
parents. His family history was notable for obesity, learn-
ing difficulties, six digits on two limbs and visual impair-
ment in his 14-year-old sister. He had also six digits on
two limbs, diagnosed at birth (Figure 1). No ultrasonogra-
phy was performed during the pregnancy or during the
neonatal period. Initial motor and mental development
milestones were abnormal, a delay noted by the family
doctor, but the diagnosis was not established in the con-
text of family history and consanguinity of the parents.
Nystagmus and pigmentary retinopathy, mild central
obesity, male hypogonadism (microtestis and microphal-
lus on genital examination), mental retardation, beha-
vioral abnormalities, hypothyroidism, and abnormal
dentition were observed. Digital abnormalities included
partial syndactyly (between the second and the third fin-
gers), fifth finger clinodactyly of both hands, brachydac-
tyly of both hands and feet, and minor scars after
surgical removal of the sixth digit of the left hand and
left foot. Renal involvement was very mild. Bilateral
renal enlargement and increased renal parenchymal
echogenicity (Figure 2) were the early findings of ima-
ging studies performed at two years old, whereas urea
and creatinine values were slightly elevated (45 mg/dL
and 1.4 mg/dL). Hypertension, type 2 diabetes mellitus,
congenital heart disease, hearing impairment or cardio-
myopathy were not identified at the first consultation.
According to the clinical and paraclinical evidence, he
met all of the six cardinal or primary criteria and six
m i n o ro rs e c o n d a r yc r i t e r i a( T a b l e1 )n e c e s s a r yf o ra
diagnosis of BBS [7]. His older sister was also diagnosed
with BBS at the same time, based on clinical assessment.
No genetic testing for BBS was available at our hospital.
T h em o t h e ra n dt h ef a m i l yd o c t o rw e r ea d v i s e dt o
check his renal status routinely; the boy was not seen
for routine medical controls for two years, until he sud-
denly developed an episode of a generalized tonic-clonic
seizure. He was admitted to the local health facility and
was found to have hypertensio n ,s e v e r ea n e m i a( h e m o -
globin 6 g/dL) and renal impairment (serum creatinine
8.5 mg/dL).
A diagnosis of BBS with ESRD was made. Due to the
elevated urea and serum creatinine levels accompanied
by uremic symptoms (loss of consciousness and general-
ized seizures), a Tenckhoff catheter was inserted and he
was initiated on daytime ambulatory peritoneal dialysis
(Figure 3).
Figure 1 Polydactyly of the fifth finger before surgery.
Figure 2 Renal ultrasonography. Bilateral renal enlargement and
increased renal parenchymal echogenicity.
Table 1 Diagnostic criteria in Bardet-Biedl syndrome
(BBS)
Primary features of BBS Secondary features of BBS
Retinal dystrophy Developmental delay
Post-axial polydactyly Behavioral problems
Obesity Neurological problems
Hypogenitalism Speech disorder
Renal abnormalities Brachydactyly, syndactyly, or clinodactyly
Learning disabilities Dental anomalies
Nephrogenic diabetes insipidus
Diabetes mellitus
Hypertension
Anosmia
Features in our patient are shown in bold.
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factory without any complications with the catheter. His
glomerular filtration rate was stabilized.
Our patient’s 14-year-old sister was not obese, and
had polydactyly in one hand and one foot. Rod-cone
dystrophy with myopia and strabismus was diagnosed at
eight years of age. Neurodevelopmental delay had been
noted since infancy, and evolved with hypotonia, dys-
praxia, poor balance, and ataxic gait. Speech and beha-
vior problems were noted, as well as learning difficulties.
No renal tract abnormalities were diagnosed. Dental
anomalies, such as crowding of the teeth, hypodontia,
and high arched palate were noticed. She has a typical
facies with enophthalmos and downward slanting pal-
pebral fissures.
Another boy, a third degree cousin in the same family,
was diagnosed with mild obesity, insulin resistance, glu-
cose intolerance, then diabetes mellitus, hypertension,
dyslipidemia, renal dysfunction, and cardiac involvement
(dilated cardiomyopathy). This patient died due to a
myocardial infarction at 28 years of age.
He also had a brother who died at nine months of
age, presenting with signs and symptoms suggestive for
cardiac failure. Both of these patients presented with
nystagmus starting from four months of age (Table 2).
Our patient’sc o u s i n ’s symptoms are more compatible
with a diagnosis of Alström syndrome, while the siblings
are closer to a diagnosis BBS. Our patient, his sister and
their cousin were included in a mutation analysis (Jack-
son Laboratory, Bar Harbor, Maine) and were screened
using a microarray (Asper Ophthalmics, Tartu, Estonia)
containing 155 published disease-causing variants and
polymorphisms in 11 BBS genes and 98 in ALMS1.O u r
patient and his cousin shared a heterozygous single
nucleotide polymorphism in BBS5 (BBS5_N184S het)
that is not disease causing. Haplotype analysis showed
that our patient and his sister shared only one allele in
the ALMS1 region, meaning that the disorder shared by
them is most likely not Alström syndrome (Figure 4).
Efforts are still being made to identify possible novel
mutations that may explain the phenotypic diagnosis.
Discussion
Recent findings in genetic research have suggested that
a large number of genetic disorders that were not pre-
viously identified in the medical literature as associated,
may, in fact, be highly related through the primary cilia.
Cilia are small, hair-like appendages attached to the sur-
face of human cells. They act like antennae, sensing and
evaluating extracellular signals to coordinate the devel-
opment and stability of a wide variety of organs. Ciliopa-
thies are a newly emerging group of genetic diseases
caused by defects in the function or structure of cellular
primary cilia. These diseases present with symptoms
such as mental retardation, retinal blindness, obesity,
polycystic kidney disease, liver fibrosis, ataxia and some
forms of cancer. Thus, BBS is a ciliopathy; a rare, multi-
tissue disorder linked to mutations in 14 different pro-
teins. The pleiotropic phenotype is due to dysfunction
of basal bodies and cilia [9,10].
The variable manifestations of BBS were initially
described by Bardet and Biedl in the 1920s [11]. Renal dys-
function has been recognized only recently to be a compo-
nent of the BBS clinical phenotype. Renal malformations
in BBS had been reported infrequently, although a high
frequency of structural abnormalities were observed post-
mortem. In one study, 26 of 57 patients (46%) had renal
structural abnormalities. However, only 5% had functional
impairment at the time of assessment [7,11].
Somwanshi reported on four cases (three males, one
female) with polydactyly, hypogonadism, retinitis pig-
mentosa, obesity, and mental retardation; however, renal
function was normal in all of these cases [12]. Pal and
Bhattacharyya described an 18-year-old woman with
pigmentary retinopathy, hypogenitalism, dwarfism, poly-
dactyly, obesity, and mental retardation, but without
renal involvement [13]. Cysts in the left kidney were
detected in a 30-year-old patient; her renal function,
however, was normal [14]. Gupta [15] reported a 20-
year-old woman with renal insufficiency and multiple
fractures, possibly related to renal osteodystrophy; her
serum creatinine level was 3.0 mg/dL and ultrasonogra-
phy revealed bilateral hypoplastic kidneys. Rathi
described the first case from India with ESRD who was
treated with continuous ambulatory peritoneal dialysis
[16]. Hooda et al. described the case of a 12-year-old
boy diagnosed as having BBS with stage III chronic kid-
ney disease that progressed to ESRD with consistent
creatinine of approximately 11 mg/dL and calculated
Figure 3 Our index patient with peritoneal dialysis catheter.
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went successful renal transplantation [17].
The frequency of renal involvement reported in BBS
varies. A questionnaire-based evaluation [7] reported
anatomic anomalies, renal insufficiency, and ESRD, with
abnormalities including renal cysts, fetal lobulation,
scarring, dysplasia, unilateral agenesis, ectopia, vesico-
ureteric reflux, and calyceal clubbing or blunting. Renal
insufficiency is noted in approximately 5% to 25% of
patients with BBS, progressing to ESRD in 4% to 10%.
Renal failure is the commonest cause of death in BBS
[16-18]. Renal histology has revealed chronic interstitial
nephritis, mesangial proliferative glomerulopathy, and
ultrastructural changes in the glomerular basement
membrane [19,20]. Most cases of BBS are diagnosed
after the first decade of life and diagnosis in early child-
hood is very rare unless there is a family history [7,10].
Our patient’s case was particularly interesting in that
he presented with ESRD at an earlier age than the most
other reported cases. The delay of diagnosis in the
context of consanguinity of the parents and the exis-
tence of similar cases in the family is surprising, but
c o u l db ee x p l a i n e db yt h er e l u c t a n c eo ft h i sf a m i l yt o
provide sufficient data to the doctors regarding the
other affected members. Also, ultrasonography during
pregnancy is not compulsory in Romania and this could
explain why the patient’s kidneys were not assessed
before birth. Even after birth, no connection was made
between the hexadactily and a possible genetic disorder.
Although the BBS/ALMS APEX array improves the
mutation detection possibilities of first-line mutation
screening, it is clear that some mutations that contribute
to these diseases remain unknown, mainly in less studied
populations. It is essential that future research endeavors
determine the prevalent mutations in such populations,
followed by inclusion of newly identified mutations on the
BBS/ALMS1 APEX chip (or other diagnostic tests), so that
appropriate genetic diagnosis, counseling, and understand-
ing of the pathogenesis and outcomes of these diseases
can be achieved in all ethnic groups.
Table 2 Comparison between our index patient and his cousin
Index patient His cousin
Nystagmus in early infancy Nystagmus and photodysphoria in early infancy
Rod-cone dystrophy, diagnosed at three years of age Progressive pigmentary retinopathy (rod-cone dystrophy) leading to
blindness
Post-axial polydactyly, hexadactyly of the fifth finger in one hand and
foot
No light perception by age 14 years
Mild central obesity Normal extremities/absence of polydactyly or syndactyly
Hypogonadism and hypogenitalism No childhood obesity, normal weight in adulthood
Renal dysfunction (end-stage renal disease) diagnosed at age 4 Normal genitalia
Mental retardation Progressive chronic nephropathy, chronic renal failure
One sister with a similar phenotype, but without renal impairment at
14 years of age
Normal intelligence
Mild to moderate bilateral sensorineural hearing loss
Congestive heart failure secondary to dilated cardiomyopathy in early
adulthood (severe)
Hyperinsulinemia/insulin resistance
Non-insulin dependent diabetes mellitus developed in early adolescence
Elevation of hepatic enzymes
Hepatic steatosis
Hepatic dysfunction
Alopecia
Low levels of growth hormone
Short stature
Advanced bone age
Hypertension
Hyperlipidemia
Hypertriglyceridemia
Atherosclerotic disease (aorta)
Hyperuricemia
Hypersecretory lungs
One brother who died in infancy with signs and symptoms suggestive for
cardiac failure
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fer from that due to any other cause and all three mod-
alities of long-term renal replacement therapy (RRT),
that is, hemodialysis, chronic peritoneal dialysis, and
renal transplantation can be offered to these individuals.
Nonetheless, it represents a very rare indication for kid-
ney transplantation.
Conclusions
Close follow-up for renal involvement in patients with
BBS and ALMS from an early age is highly recom-
mended to prevent ESRD and also so renal replacement
therapy can be started immediately.
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Figure 4 Pedigree and haplotype. Our index patient (1) and his sister (2) share only one halplotype in the Alström region. Additionally, the
haplotype they share is not the same as their cousins (3-5). Our patient’s cousin (4) and patient’s sister (2) share a single nucleotide
polymorphism (non-disease causing) in Bardet-Biedl syndrome 5 (BBS5), which was probably passed down from their grandfather. It is not really
relevant, because it is not causative. Our patient’s cousin is homozygous in the ALMS1 region and his brother is a ‘carrier’, which suggests a
diagnosis of Alström syndrome could be correct.
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